#FDA

Curated entries containing this keyword across available languages.

Sinsi hastalık, ilk belirtiden 20 yıl önce başlıyor! Bu hatalar Alzheimer’a zemin hazırlıyor

EN #FDA

9/22/26

Alzheimer's disease begins in the brain years before the first symptoms

Neurology Specialist Prof. Dr. Neşe Tuncer stated that the Alzheimer's process begins 20 years before symptoms and explained risk factors and precautions.

News Science & Health

EN #FDA

9/18/26

Virtual Biotech Company Established with Artificial Intelligence Agents Starts Drug Development Operations

A team of researchers from Stanford Medicine has launched a virtual startup that develops cancer treatment strategies and analyzes clinical data using tens of thousands of artificial intelligence agents.

News Artificial Intelligence

FDA Keeps Radiology AI Revenue Tied to Premarket Clearance | PYMNTS.com

EN #FDA

9/17/26

FDA Imposes Approval Requirement for Radiology AI and Mastercard Partners with Alchemy

The FDA tied the revenue generation of radiology AI software to premarket clearance, while Mastercard and Alchemy developed a payment solution for AI agents.

News Artificial Intelligence

How AI is rewriting the rules for medicine and biotech in Mass.

EN #FDA

9/15/26

Artificial Intelligence is Transforming the Medical and Biotechnology Sector

Health leaders gathered at an event in Cambridge stated that artificial intelligence is accelerating drug discovery and changing patient care approaches.

News Artificial Intelligence

ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure

EN #FDA

9/9/26

Autonomous AI-Powered ADVOCATE Program for Heart Failure Treatment

The ADVOCATE program, launched to improve the treatment processes of heart failure patients, is receiving millions of dollars in funding.

News Artificial Intelligence

EN #FDA

9/6/26

Optogenetic Treatment Era in Retinal Diseases and Night Blindness

Developed against the risk of blindness and receiving FDA approval, the light gene therapy will begin to be applied for patients next year.

News Science & Health

FDA clears new imaging software from AI company founded by cardiologists

EN #FDA

9/4/26

FDA Approves AI Software from Cardiologist-Founded Company

Tennessee-based medical technology company Heartvue.ai has received clearance from the US Food and Drug Administration for its new AI-powered software that analyzes cardiac MRI scans.

News Artificial Intelligence Technology

FDA pilot offers generative AI medical devices a path to patients before they are authorized

EN #FDA

9/3/26

FDA's New Pilot Program Clears Path for Artificial Intelligence Devices

The TEMPO program temporarily facilitates the market introduction of certain artificial intelligence-powered medical devices.

News Artificial Intelligence

US medical groups urge people to get flu and Covid shots in counter to Trump guidance

EN #FDA

9/2/26

US Medical Organizations Issue Fall Vaccine Recommendations

Leading US medical organizations have released their autumn flu and Covid-19 vaccine guidelines to clear up confusion caused by changing official recommendations.

News World

Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes

EN #FDA

8/26/26

FDA Approval for Abbott's World's First Dual-Sensor Device for Diabetes Patients

Abbott has received approval from the U.S. Food and Drug Administration for the world's first dual-sensor system that helps prevent diabetic ketoacidosis by tracking ketone levels in diabetes patients.

News World

Details

Results: 10
Articles: 10
Categories: 0
Content Types: 0
Current Language: EN
Languages: EN (10)

X LinkedIn Facebook WhatsApp Telegram

#FDA

Related Articles

Alzheimer's disease begins in the brain years before the first symptoms

Virtual Biotech Company Established with Artificial Intelligence Agents Starts Drug Development Operations

FDA Imposes Approval Requirement for Radiology AI and Mastercard Partners with Alchemy

Artificial Intelligence is Transforming the Medical and Biotechnology Sector

Autonomous AI-Powered ADVOCATE Program for Heart Failure Treatment

Optogenetic Treatment Era in Retinal Diseases and Night Blindness

FDA Approves AI Software from Cardiologist-Founded Company

FDA's New Pilot Program Clears Path for Artificial Intelligence Devices

US Medical Organizations Issue Fall Vaccine Recommendations

FDA Approval for Abbott's World's First Dual-Sensor Device for Diabetes Patients

Details

Share